BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1746 related articles for article (PubMed ID: 17919544)

  • 21. Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials.
    Likar R; Kayser H; Sittl R
    Clin Ther; 2006 Jun; 28(6):943-52. PubMed ID: 16860176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of fentanyl and buprenorphine in an experimental model of pain and central sensitization in human volunteers.
    Tröster A; Ihmsen H; Singler B; Filitz J; Koppert W
    Clin J Pain; 2012 Oct; 28(8):705-11. PubMed ID: 22469638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The hypoalgesic effect of tramadol in relation to CYP2D6.
    Poulsen L; Arendt-Nielsen L; Brøsen K; Sindrup SH
    Clin Pharmacol Ther; 1996 Dec; 60(6):636-44. PubMed ID: 8988065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic/pharmacodynamic modeling of psychomotor impairment induced by oral clonazepam in healthy volunteers.
    dos Santos FM; Gonçalves JC; Caminha R; da Silveira GE; Neves CS; Gram KR; Ferreira CT; Jacqmin P; Noël F
    Ther Drug Monit; 2009 Oct; 31(5):566-74. PubMed ID: 19730280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analgesic efficacy of celecoxib in postoperative oral surgery pain: a single-dose, two-center, randomized, double-blind, active- and placebo-controlled study.
    Cheung R; Krishnaswami S; Kowalski K
    Clin Ther; 2007; 29 Suppl():2498-510. PubMed ID: 18164917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic-pharmacodynamic modeling of morphine and oxycodone concentrations and analgesic effect in a multimodal experimental pain model.
    Staahl C; Upton R; Foster DJ; Christrup LL; Kristensen K; Hansen SH; Arendt-Nielsen L; Drewes AM
    J Clin Pharmacol; 2008 May; 48(5):619-31. PubMed ID: 18440921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics, efficacy, and tolerability of fentanyl following intranasal versus intravenous administration in adults undergoing third-molar extraction: a randomized, double-blind, double-dummy, two-way, crossover study.
    Christrup LL; Foster D; Popper LD; Troen T; Upton R
    Clin Ther; 2008 Mar; 30(3):469-81. PubMed ID: 18405786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
    O'Farrell AM; van Vliet A; Abou Farha K; Cherrington JM; Campbell DA; Li X; Hanway D; Li J; Guler HP
    Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analgesic efficacy of the cyclooxygenase-inhibiting nitric oxide donor AZD3582 in postoperative dental pain: Comparison with naproxen and rofecoxib in two randomized, double-blind, placebo-controlled studies.
    Michael Hill C; Sindet-Pederson S; Seymour RA; Hawkesford JE; Coulthard P; Lamey PJ; Gerry Cowan C; Wickens M; Jeppsson L; Dean AD; Svensson O
    Clin Ther; 2006 Sep; 28(9):1279-95. PubMed ID: 17062301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic-pharmacodynamic relationships of cognitive and psychomotor effects of intravenous buprenorphine infusion in human volunteers.
    Jensen ML; Sjøgren P; Upton RN; Foster DJ; Bonde P; Graae C; Skram U; Stevner L; Christrup LL
    Basic Clin Pharmacol Toxicol; 2008 Jul; 103(1):94-101. PubMed ID: 18598301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-bedtime dosing with indiplon in adults and the elderly: results from two placebo-controlled, active comparator crossover studies in healthy volunteers.
    Farber RH; Burke PJ
    Curr Med Res Opin; 2008 Mar; 24(3):837-46. PubMed ID: 18257978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism-based PK/PD modeling of the respiratory depressant effect of buprenorphine and fentanyl in healthy volunteers.
    Yassen A; Olofsen E; Romberg R; Sarton E; Teppema L; Danhof M; Dahan A
    Clin Pharmacol Ther; 2007 Jan; 81(1):50-8. PubMed ID: 17185999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic and pharmacodynamic modelling after subcutaneous, intravenous and buccal administration of a high-concentration formulation of buprenorphine in conscious cats.
    Doodnaught GM; Monteiro BP; Benito J; Edge D; Beaudry F; Pelligand L; Steagall P
    PLoS One; 2017; 12(4):e0176443. PubMed ID: 28445495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing the subjective, psychomotor and physiological effects of intravenous buprenorphine and morphine in healthy volunteers.
    Zacny JP; Conley K; Galinkin J
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1187-97. PubMed ID: 9316825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of buprenorphine after intravenous administration of clinical doses to dogs.
    Andaluz A; Moll X; Abellán R; Ventura R; Carbó M; Fresno L; García F
    Vet J; 2009 Sep; 181(3):299-304. PubMed ID: 18467137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of the seven-day buprenorphine transdermal system in opioid-naïve patients with moderate to severe chronic low back pain: an enriched, randomized, double-blind, placebo-controlled study.
    Steiner DJ; Sitar S; Wen W; Sawyerr G; Munera C; Ripa SR; Landau C
    J Pain Symptom Manage; 2011 Dec; 42(6):903-17. PubMed ID: 21945130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No evidence of potentiation of buprenorphine by milnacipran in healthy subjects using a nociceptive test battery.
    Okkerse P; Alvarez-Jimenez R; Hay JL; Tehim A; Kumar R; de Kam ML; Groeneveld GJ
    Eur J Pain; 2017 Mar; 21(3):494-506. PubMed ID: 27651026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic and pharmacodynamic modelling of intravenous, intramuscular and subcutaneous buprenorphine in conscious cats.
    Steagall PV; Pelligand L; Giordano T; Auberger C; Sear JW; Luna SP; Taylor PM
    Vet Anaesth Analg; 2013 Jan; 40(1):83-95. PubMed ID: 22998333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-dose intravenous tramadol for acute migraine pain in adults: a single-blind, prospective, randomized, placebo-controlled clinical trial.
    Alemdar M; Pekdemir M; Selekler HM
    Clin Ther; 2007 Jul; 29(7):1441-7. PubMed ID: 17825695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 88.